120 related articles for article (PubMed ID: 10779697)
1. kappa-opioid agonist stimulated regional distribution of [(35)S]GTPgammas binding in butorphanol continuously infused rat.
Park Y; Jang CG; Ho IK; Ko KH
Brain Res Bull; 2000 May; 52(1):17-20. PubMed ID: 10779697
[TBL] [Abstract][Full Text] [Related]
2. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
Childers SR; Xiao R; Vogt L; Sim LJ
Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
[TBL] [Abstract][Full Text] [Related]
4. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
Sim-Selley LJ; Daunais JB; Porrino LJ; Childers SR
Neuroscience; 1999; 94(2):651-62. PubMed ID: 10579225
[TBL] [Abstract][Full Text] [Related]
5. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
6. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
7. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
8. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
9. Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.
Martin TJ; Sexton T; Kim SA; Severino AL; Peters CM; Young LJ; Childers SR
Neuroscience; 2015 Dec; 311():422-9. PubMed ID: 26523979
[TBL] [Abstract][Full Text] [Related]
10. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated activation of G-proteins by kappa opioid agonists in frog (Rana esculenta) brain membranes.
Rottmann M; Fábián G; Spicher K; Offermanns S; Szücs M
Brain Res Bull; 1998 Mar; 45(5):467-74. PubMed ID: 9570716
[TBL] [Abstract][Full Text] [Related]
12. Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression.
Tanaka S; Fan LW; Tien LT; Park Y; Liu-Chen LY; Rockhold RW; Ho IK
J Neurosci Res; 2005 Oct; 82(2):255-63. PubMed ID: 16130146
[TBL] [Abstract][Full Text] [Related]
13. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.
Sim LJ; Liu Q; Childers SR; Selley DE
J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574
[TBL] [Abstract][Full Text] [Related]
14. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
15. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
16. 8-Carboxamidocyclazocine: a long-acting, novel benzomorphan.
Bidlack JM; Cohen DJ; McLaughlin JP; Lou R; Ye Y; Wentland MP
J Pharmacol Exp Ther; 2002 Jul; 302(1):374-80. PubMed ID: 12065740
[TBL] [Abstract][Full Text] [Related]
17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
18. Crosstolerance between butorphanol and morphine in rats.
Feng YZ; Narita M; Tseng YT; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1994 Nov; 49(3):657-61. PubMed ID: 7862721
[TBL] [Abstract][Full Text] [Related]
19. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
20. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
